Literature DB >> 7564387

Typical medullary carcinoma of the breast: a clinical and pathological analysis of 52 cases.

M Reinfuss1, A Stelmach, J Mitus, J Rys, K Duda.   

Abstract

Fifty-two women with typical medullary breast carcinoma, diagnosed according to criteria of Ridolfi et al. [Cancer 40:1365-1385, 1977] are described. At the time of diagnosis, 90% of the patients were stages I and II. The primary tumor size was < or = to 4 cm in 46 (88.5%) and > 4 cm in 6 (11.5%) patients. Axillary lymph nodes were microscopically negative in 35 (67.3%) and positive in 17 (32.7%) patients. All 52 women underwent the Patey operation. Seventeen patients with microscopically positive axillary lymph nodes received postoperative irradiation. Of the 52 treated patients, 44 (84.6%) survived 10 years NED. The only prognostic factor was the microscopical axillary lymph nodes status. In the group of pNO patients, 97.1% survived 10 years NED, pN+ 58.8% only. The sole causes of unsuccessful treatment were distant metastases to lungs, hepar, and bones. Typical medullary carcinoma is a favorable histological type of breast carcinoma with very good prognosis for pNO patients.

Entities:  

Mesh:

Year:  1995        PMID: 7564387     DOI: 10.1002/jso.2930600205

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  12 in total

1.  Medullary carcinoma of the breast: a population-based perspective.

Authors:  Steve R Martinez; Shannon H Beal; Robert J Canter; Steven L Chen; Vijay P Khatri; Richard J Bold
Journal:  Med Oncol       Date:  2011-09       Impact factor: 3.064

2.  Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials.

Authors:  J Huober; S Gelber; A Goldhirsch; A S Coates; G Viale; C Öhlschlegel; K N Price; R D Gelber; M M Regan; B Thürlimann
Journal:  Ann Oncol       Date:  2012-06-14       Impact factor: 32.976

3.  Immunophenotype of lymphocytic infiltration in medullary carcinoma of the breast.

Authors:  Hajime Kuroda; Jun-ichi Tamaru; Goi Sakamoto; Kiyoshi Ohnisi; Shinji Itoyama
Journal:  Virchows Arch       Date:  2004-11-30       Impact factor: 4.064

4.  [Diagnosis and immunohistochemistry of medullary breast cancer].

Authors:  S Milde; J Gaedcke; R v Wasielewski; H Bruchardt; L Wingen; D Gadzicki; H Arps; H H Kreipe
Journal:  Pathologe       Date:  2006-09       Impact factor: 1.011

5.  Clinicopathologic characteristics at diagnosis and the survival of patients with medullary breast carcinoma in China: a comparison with infiltrating ductal carcinoma-not otherwise specified.

Authors:  A-Yong Cao; Min He; Liang Huang; Zhi-Ming Shao; Gen-Hong Di
Journal:  World J Surg Oncol       Date:  2013-04-22       Impact factor: 2.754

6.  A locally advanced breast cancer with difficult differential diagnosis of carcinosarcoma and atypical medullary carcinoma, which had poor response to adriamycin- and taxane-based neoadjuvant chemotherapy: a case report.

Authors:  Se Hyun Kim; Hyun Cheol Chung; Jaeheon Jeong; Ji Hoon Kim; Sun Young Rha; Joong Bae Ahn; Nam Hoon Cho; Hei-Cheul Jeung
Journal:  Cancer Res Treat       Date:  2007-09-30       Impact factor: 4.679

7.  Medullary carcinoma of the breast: Role of contrast-enhanced MRI in the diagnosis of multiple breast lesions.

Authors:  Sn Abdul Rashid; K Rahmat; Kj Jayaprasagam; K Alli; F Moosa
Journal:  Biomed Imaging Interv J       Date:  2009-10-01

8.  Medullary breast carcinoma: a pathogenic review and immunohistochemical study using tissue microarray.

Authors:  Ming Lee; Ana Richelia Jara-Lazaro; Poh Yian Cheok; Aye Aye Thike
Journal:  Singapore Med J       Date:  2022-07       Impact factor: 3.331

9.  Comparison of the characteristics of medullary breast carcinoma and invasive ductal carcinoma.

Authors:  Inhye Park; Jiyoung Kim; Minkuk Kim; Soo Youn Bae; Se Kyung Lee; Won Ho Kil; Jeong Eon Lee; Seok Jin Nam
Journal:  J Breast Cancer       Date:  2013-12-31       Impact factor: 3.588

10.  Prognostic value of morphology and hormone receptor status in breast cancer - a population-based study.

Authors:  C Allemani; M Sant; F Berrino; T Aareleid; G Chaplain; J W Coebergh; M Colonna; P Contiero; A Danzon; M Federico; L Gafà; P Grosclaude; G Hédelin; J Macè-Lesech; C M Garcia; E Paci; N Raverdy; B Tretarre; E M I Williams
Journal:  Br J Cancer       Date:  2004-10-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.